臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationStatement: 慢性結膜炎的用藥聲明資料

Generated Narrative: MedicationStatement med-sta-inflamed-example

status: Active

category: 門診

medication: 鹽酸四環素眼藥膏

subject: 陳加玲(official) Female, DoB: 1990-01-01 ( Medical record number (use: official, ))

effective: 2023-11-05 08:00:00+0800

dateAsserted: 2023-11-05 10:00:00+0800

reasonCode: 慢性結膜炎

note: 每天早晚塗抹發炎處

Dosages

-TextTimingRoute
*每天早晚塗抹發炎處2 per 1 days外用